Brought to you by 
Exelixis licenses Wisconsin Alumni Research's technology
19 Jul 2000
Executive Summary
Exelixis has licensed genetic mouse technology from Wisconsin Alumni Research Foundation's Dr. William Dove. Exelixis will use the technology to identify genes associated with disease or to identify and validate drug targets in vertebrate systems.
Deal Industry
- Pharmaceuticals
-
Biotechnology
-
Drug Discovery Tools
- Genomics-Proteomics
-
Drug Discovery Tools
Deal Status
- Final
Deal Type
-
Alliance
- R&D and Marketing (Licensing)
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Exelixis licenses Wisconsin Alumni Research's technology
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice